UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047329
Receipt number R000053956
Scientific Title A Study on the Effect of Food Containing Plant Extract on lipid metabolism -A Randomized, Double-blind, Placebo-controlled, Parallel-group Study-
Date of disclosure of the study information 2022/03/31
Last modified on 2022/10/07 14:35:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on the Effect of Food Containing Plant Extract on lipid metabolism
-A Randomized, Double-blind, Placebo-controlled, Parallel-group Study-

Acronym

A Study on the Effect of Food Containing Plant Extract on lipid metabolism

Scientific Title

A Study on the Effect of Food Containing Plant Extract on lipid metabolism
-A Randomized, Double-blind, Placebo-controlled, Parallel-group Study-

Scientific Title:Acronym

A Study on the Effect of Food Containing Plant Extract on lipid metabolism

Region

Japan


Condition

Condition

No

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the effect of food containing plant extract on lipid metabolism.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

blood lipid

Key secondary outcomes

Questionnaire


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Foods containing plant extract, 8 weeks consumption

Interventions/Control_2

Foods not containing plant extract, 8 weeks consumption

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

29 years-old >=

Gender

Male

Key inclusion criteria

(1) Healthy males aged 20 to 29 years-old.
(2) Subjects whose BMI are under 25.
(3) Subjects who have exercise habits (at least 30 min of exercise twice a week for more than one year).
(4) Subjects who can make self-judgment and are voluntarily giving written informed consent.

Key exclusion criteria

(1) Subjects who were diagnosed with serious disease (e.g., diabetes, liver disease, kidney disease, digestive disease, heart disease, respiratory disease and/or peripheral vascular disease).
(2) Subjects who had a gastrointestinal surgery.
(3) Subjects with abnormal parameters in liver and/or kidney function.
(4) Subjects with a disease currently under treatment.
(5) Subjects with drug or food allergies.
(6) Subjects with anemic.
(7) Subjects who are on a diet.
(8) Subjects who with irregular life patterns.
(9) Subjects who can't stop using functional foods (including Food for Specified Health Uses or Foods with Function Claims) and/or Specified quasi-drugs during the current study periods.
(11) Subjects who drink excessive alcohol.
(12) Subjects who can't stop drinking from one day before each measurement.
(13) Subjects who have donated over 200 mL of blood and/or blood components within the last 4 weeks prior to the current study.
(14) Subjects who are participating in other studies or planning to participate at the start of the current study.
(15) Subjects who are judged as unsuitable for the current study by the investigator for other reasons.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Naoki
Middle name
Last name Miura

Organization

Miura Clinic, Medical Corporation Kanonkai

Division name

Internal Medicine

Zip code

530-0044

Address

Higashitenma building 9F, 1-7-17, Higashitenma, Kita-ku, Osaka, Osaka

TEL

06-6135-5200

Email

mterashima@miula.co.jp


Public contact

Name of contact person

1st name Makoto
Middle name
Last name Terashima

Organization

Oneness support Co., Ltd.

Division name

Clinical trial Division

Zip code

530-0044

Address

Higashitenma building 4F, 1-7-17, Higashitenma, Kita-ku, Osaka, Osaka

TEL

06-4801-8917

Homepage URL


Email

mterashima@oneness-sup.co.jp


Sponsor or person

Institute

Oneness support Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

TOYO SHINYAKU Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Miura Clinic, Medical Corporation Kanonkai

Address

Higashitenma building 9F, 1-7-17, Higashitenma, Kita-ku, Osaka, Osaka

Tel

06-6135-5200

Email

mterashima@miula.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 03 Month 23 Day

Date of IRB

2022 Year 03 Month 24 Day

Anticipated trial start date

2022 Year 04 Month 01 Day

Last follow-up date

2022 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 03 Month 30 Day

Last modified on

2022 Year 10 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053956